Protagonist Therapeutics, Inc

PTGX

—

Advanced chart & tools →

Protagonist Therapeutics, IncPTGX

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.05

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$46.02M

Net income

$-130.15M

Net margin

-282.8%

Gross margin

—

Dividends & financials

Protagonist Therapeutics, Inc (PTGX) reported revenue of $46.02M and net income of $-130.15M, or $-2.05 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.